Recent studies have linked glucagon-like peptide-1 (GLP-1) receptor agonistTrusted Source medications, such ...

Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...

Novo Nordisk has multiple weight-loss drugs in various stages of development and approval, according to its R&D pipeline. These include, among others, monlunabant (phase 2); oral and subcutaneous ...

Ivim Health reports that peptide therapies, spurred by GLP-1 interest, require careful understanding and medical oversight for safe use.

GLP-1 receptor agonists may confer neuroprotection via reduced neuroinflammation, inhibited apoptosis, and vasodilatory effects that enhance cerebral perfusion through cAMP and VEGF-related pathways.

Researchers create the first sex-specific GLP-1 brain atlas, revealing why weight-loss drugs work differently in men and women.

Can the neurovascular effects of GLP-1s play a role in treating migraine?

Burn Slim uses the 'gelatin trick' to activate GLP-1 and GIP hormones naturally. 2026 full report: ingredients, science, pricing, and results.

Less than two weeks after Pfizer struck a deal with a Chinese drugmaker to gain commercial rights to a GLP-1 drug, the country’s National Medical Products Administration (NMPA) has ...

Taking magnesium with a GLP-1 like Ozempic? Learn how they can interact, potential digestive effects, and key safety tips.